Αποτελέσματα Αναζήτησης
27 Φεβ 2024 · The Vaccine study confirmed that the Moderna and Pfizer/BioNTech vaccines are linked in rare cases to myocarditis and pericarditis, conditions involving inflammation of the heart muscle and...
26 Φεβ 2024 · The study, published in Vaccine, confirmed previously identified rare safety signals for myocarditis and pericarditis after a mRNA vaccine (Pfizer and Moderna) and Guillain-Barré syndrome and cerebral venous sinus thrombosis (CVST) after viral vector vaccines (AstraZeneca).1
2 Ιουλ 2024 · Some side effects of COVID-19 mRNA (Moderna) vaccine may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.
Nine received the Pfizer vaccine and 11 received the Moderna vaccine. All 20 patients were hospitalized and most patients presented with petechiae, bruising or mucosal bleeding (gingival, vaginal, epistaxis) with onset of symptoms between 1–23 days (median 5 days) post vaccination.
RESULTS: The most frequent adverse events following COVID-19 vaccine described in the literature are represented by audiovestibular symptoms, such as tinnitus, sudden sensorineu-ral hearing loss, vertigo, and dizziness. Other side effects include facial nerve palsy, epistaxis, and oral manifestations (lichen planus, bleeding, ulcers, and vesicles).
24 Σεπ 2021 · In this study, cohort participants vaccinated with the adenovirus-vectored vaccine reported mild bleeding episodes significantly more often compared to recipients of mRNA vaccines. Women were more than twice as likely as men to experience bleeding episodes.
6 Απρ 2021 · The CDC estimates suggest that anaphylaxis (signs of trouble breathing, swelling of the face and throat, rash, and low blood pressure) occurs soon after vaccination in 2.5 cases per million doses among people receiving the mRNA-1273 vaccine. 19 Based on the “Morbidity and Mortality Weekly Report” from first month of COVID-19 vaccine safety ...
